Comparison of European and U.S. results for cephalosporin versus penicillin treatment of group A streptococcal tonsillopharyngitis

Article

Abstract

The outcome of cephalosporin versus penicillin treatment of group A streptococcal tonsillopharyngitis may differ between Europe and the USA. In the present study, Medline, Embase, reference lists, and abstract searches were used to identify randomized, controlled trials of cephalosporin versus penicillin treatment of group A streptococcal (GAS) tonsillopharyngitis. The outcomes of interest were bacteriologic and clinical cure rates from investigations conducted in Europe versus those conducted in the USA. Forty-seven trials involving 11,426 patients were included in the meta-analyses. For the comparison of 10 days of treatment with cephalosporins versus 10 days of treatment with penicillin, there were ten European and 25 U.S. trials, all involving pediatric subjects. The overall odds ratio (OR) favored cephalosporins more strongly in bacteriologic cure rate in Europe (OR=4.27, p<0.00001) than in the USA (OR=2.70, p<0.00001). Studies of 4–5 days of cephalosporin treatment versus 10 days of penicillin treatment were also analyzed. For nine European trials, the OR significantly favored cephalosporins (OR=1.30, p=0.03) in bacteriologic cure rates, but not as strongly as in the USA, (OR=2.41, p<0.00001). When results for 4–5 days of cephalosporin treatment were divided into pediatric versus adult populations, the differences in bacteriologic eradication rates obtained with cephalosporins were more pronounced in children. The likelihood of bacteriologic and clinical failure of GAS tonsillopharyngitis treatment in both European and U.S. patients is significantly less if a 10-day course of oral cephalosporin is prescribed, and is at least similar, if not significantly less, with a 4- to 5-day course of oral cephalosporin compared with a 10-day course of oral penicillin.

References

  1. 1.
    Kaplan E (1985) Benzathine penicillin G for the treatment of group A streptococcal pharyngitis: a reappraisal in 1985. Pediatr Infect Dis J 4:592–596Google Scholar
  2. 2.
    Breese B, Disney F (1955) The successful treatment of beta-hemolytic streptococcal infections in children with a single injection of respiratory penicillin (benzathine penicillin G). Pediatrics 15:516–521PubMedGoogle Scholar
  3. 3.
    Breese B, Disney F (1957) A comparison of intramuscular and oral benzathine penicillin G in the treatment of streptococcal infections in children. J Pediatr 51:157–163PubMedCrossRefGoogle Scholar
  4. 4.
    Breese B, Disney F (1958) Penicillin in the treatment of streptococcal infections: a comparison of five different oral and one parenteral form. N Engl J Med 259:57–62PubMedCrossRefGoogle Scholar
  5. 5.
    Kaplan E, Top F Jr, Budding B et al (1971) Diagnosis of streptococcal pharyngitis: differentiation of active infection from the carrier state in the symptomatic child. J Infect Dis 123:490–501PubMedGoogle Scholar
  6. 6.
    Kaplan E, Gastanaduy A, Huwe B (1981) The role of the carrier in the treatment failures after antibiotic therapy for group A streptococci in the upper respiratory tract. J Lab Clin Med 98:326–335PubMedGoogle Scholar
  7. 7.
    Kaplan E, Johnson D (2001) Unexplained reduced microbiological efficacy of intramuscular benzathine penicillin G and oral penicillin V in eradication of group A streptococci from children with acute pharyngitis. Pediatrics 108:1180–1186PubMedCrossRefGoogle Scholar
  8. 8.
    Curtin-Wirt C, Casey J, Murray P et al (2003) Efficacy of penicillin vs. amoxicillin in children with group A beta hemolytic streptococcal tonsillopharyngitis. Clin Pediatr 42:219–225CrossRefGoogle Scholar
  9. 9.
    Pichichero M, Margolis P (1991) A comparison of cephalosporins and penicillins in the treatment of group A beta-hemolytic streptococcal pharyngitis: a meta-analysis supporting the concept of microbial copathogenicity. Pediatr Infect Dis J 10:275–281PubMedCrossRefGoogle Scholar
  10. 10.
    Casey JR, Pichichero ME (2004) Meta-analysis of cephalosporins versus penicillin for treatment of group A streptococcal tonsillopharyngitis in children. Pediatrics 113:866–882PubMedCrossRefGoogle Scholar
  11. 11.
    Shulman S, Gerber M (2004) So what’s wrong with penicillin for strep throat? Pediatrics 113:1816–1819PubMedCrossRefGoogle Scholar
  12. 12.
    Casey JR, Pichichero ME (2004) Meta-analysis of cephalosporins versus penicillin for treatment of group A streptococcal tonsillopharyngitis in adults. Clin Infect Dis 38:1526–1534PubMedCrossRefGoogle Scholar
  13. 13.
    Bisno A (2004) Are cephalosporins superior to penicillin for treatment of acute streptococcal pharyngitis? Clin Infect Dis 38:1535–1537PubMedCrossRefGoogle Scholar
  14. 14.
    Jadad A, Moore R, Carroll D et al (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17:1–12PubMedCrossRefGoogle Scholar
  15. 15.
    Markowitz M, Gerber M, Kaplan E (1993) Treatment of streptococcal pharyngotonsillitis: reports of penicillin’s demise are premature. J Pediatr 123:679–685PubMedCrossRefGoogle Scholar
  16. 16.
    Peto R, Colins R, Gray R (1995) Large-scale randomized evidence: large, simple trials and overviews of trials. J Clin Epidemiol 48:23–40PubMedCrossRefGoogle Scholar
  17. 17.
    DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188PubMedCrossRefGoogle Scholar
  18. 18.
    Laupacis A, Sackett DL, Roberst RS (1988) An assessment of clinically useful measures of the consequences of treatment. N Engl J Med 318:1728–1733PubMedCrossRefGoogle Scholar
  19. 19.
    Thompson S (1994) Why sources of heterogeneity in meta-analysis should be investigated. BMJ 309:1351–1355PubMedGoogle Scholar
  20. 20.
    Rabinovitch M, MacKenzie R, Brazeau M et al (1973) Treatment of streptococcal pharyngitis. I. Clinical evaluation. Can Med Assoc J 108:1271–1274PubMedGoogle Scholar
  21. 21.
    Hennes DM (1982) A clinical experience with cefadroxil in upper respiratory tract infection. J Antimicrob Chemother 10(Suppl B):125–135Google Scholar
  22. 22.
    Milatovic D, Knauer J (1989) Cefadroxil versus penicillin in the treatment of streptococcal tonsillopharyngitis. Eur J Clin Microbiol Infect Dis 8:282–288PubMedCrossRefGoogle Scholar
  23. 23.
    Holm S, Henning C, Grahn E et al (1995) Is penicillin the appropriate treatment for recurrent tonsillopharyngitis? Results from a comparative randomized blind study of cefuroxime axetil and phenoxymethylpenicillin in children. The Swedish Study Group. Scand J Infect Dis 27:221–228PubMedCrossRefGoogle Scholar
  24. 24.
    Milatovic D, Adam D, Hamilton H et al (1993) Cefprozil versus penicillin V in treatment of streptococcal tonsillopharyngitis. Antimicrob Agents Chemother 37:1620–1623PubMedGoogle Scholar
  25. 25.
    Holm SE, Roos K, Stromberg A (1991) A randomized study of treatment of streptococcal pharyngotonsillitis with cefadroxil or phenoxymethylpenicillin (penicillin V). Pediatr Infect Dis J 10(Suppl 10):S68–S71PubMedGoogle Scholar
  26. 26.
    Cerselotte E, Vandenberghe P, Bradbury F (1990) Cefetamet pivoxil and penicillin V in the treatment of group A beta-haemolytic streptococcal pharyngitis. Acta Ther 16:163–173Google Scholar
  27. 27.
    Ramet J, Peyramond D, Vandenberghe P et al (1992) Comparative study of cefatamet pivoxil and penicillin V in the treatment of group A beta-hemolytic streptococcal pharyngitis. Chemotherapy 38(Suppl 2):33–37PubMedCrossRefGoogle Scholar
  28. 28.
    Gervaix A, Brighi L, Halperin DS et al (1995) Cefetamet pivoxil in the treatment of pharyngotonsillitis due to group A beta hemolytic streptococci: preliminary report. J Chemother 7(Suppl 1):21–24PubMedGoogle Scholar
  29. 29.
    Roos K, Larsson P (1997) Loracarbef versus phenoxymethylpenicillin in the treatment of recurrent streptococcal pharyngotonsillitis. Scand J Infect Dis 29:141–145PubMedCrossRefGoogle Scholar
  30. 30.
    Stillerman M (1970) Comparison of cephaloglycin and penicillin in streptococcal pharyngitis. Clin Pharmacol Ther 11:205–213PubMedGoogle Scholar
  31. 31.
    Disney FA, Breese BB, Green JL et al (1971) Cephalexin and penicillin therapy of childhood beta-hemolytic streptococcal infections. Postgrad Med J 47(Suppl):47–51PubMedGoogle Scholar
  32. 32.
    Stillerman M, Isenberg HD, Moody M (1972) Streptococcal pharyngitis therapy: comparison of cephalexin, phenoxymethyl penicillin and ampicillin. Am J Dis Child 123:457–461PubMedGoogle Scholar
  33. 33.
    Disney FA, Breese BB, Francis AB et al (1979) The use of cefaclor in the treatment of beta-haemolytic streptococcal throat infections in children. Postgrad Med J 55(Suppl 4):50–52PubMedGoogle Scholar
  34. 34.
    Stillerman M, Isenberg H (1970) Streptococcal pharyngitis therapy: comparison of cyclacillin, cephalexin and potassium penicillin V. Antimicrob Agents Chemother 2:270–276Google Scholar
  35. 35.
    Ginsburg CM, McCracken GH Jr, Steinberg JB et al (1982) Treatment of group A streptococcal pharyngitis in children. Results of a prospective, randomized study of four antimicrobial agents. Clin Pediatr (Phila) 21:83–88Google Scholar
  36. 36.
    Ginsburg CM, McCracken GH Jr, Crow SD et al (1980) A controlled comparative study of penicillin V and cefadroxil therapy of group A streptococcal tonsillopharyngitis. J Int Med Res 8(Suppl 1):82–86PubMedGoogle Scholar
  37. 37.
    Randolf M (1984) Recurrence rate in streptococcal pharyngitis with b.i.d. cefadroxil or t.i.d. penicillin V-K. Todays Ther Trends 2:1–6Google Scholar
  38. 38.
    Stillerman M (1986) Comparison of oral cephalosporins with penicillin therapy for group A streptococcal pharyngitis. Pediatr Infect Dis 5:649–654PubMedGoogle Scholar
  39. 39.
    Gerber M, Randolph M, Chanatry J et al (1986) Once daily therapy for streptococcal pharyngitis with cefadroxil. J Pediatr 109:531–537PubMedCrossRefGoogle Scholar
  40. 40.
    Pichichero M, Disney F, Aronovitz G et al (1987) A multicenter, randomized, single-blind evaluation of cefuroxime axetil and phenoxymethylpenicillin in the treatment of streptococcal pharyngitis. Clin Pediatr 26:453–458CrossRefGoogle Scholar
  41. 41.
    Pichichero ME, Disney FA, Aronovitz GH et al (1987) Randomized, single-blind evaluation of cefadroxil and phenoxymethylpenicillin in the treatment of streptococcal pharyngitis. Antimicrob Agents Chemother 31:903–906PubMedGoogle Scholar
  42. 42.
    Gooch WM III, Swenson E, Higbee MD et al (1987) Cefuroxime axetil and penicillin V compared in the treatment of group A beta-hemolytic streptococcal pharyngitis. Clin Ther 9:670–677PubMedGoogle Scholar
  43. 43.
    Goldfarb J, Lemon E, O’Horo J et al (1988) Once-daily cefadroxil versus oral penicillin in the pediatric treatment of streptococcal pharyngitis. Clin Ther 10:178–182PubMedGoogle Scholar
  44. 44.
    Pichichero ME, Gooch WM, Rodriguez W et al (1994) Effective short-course treatment of acute group A beta-hemolytic streptococcal tonsillopharyngitis. Ten days of penicillin V versus 5 or 10 days of cefpodoxime therapy in children. Arch Pediatr Adolesc Med 148:1053–1060PubMedGoogle Scholar
  45. 45.
    Reed BD, Huck W, Zazove P (1991) Treatment of beta-hemolytic streptococcal pharyngitis with cefaclor or penicillin. Efficacy and interaction with beta-lactamase-producing organisms in the pharynx. J Fam Pract 32:138–144PubMedGoogle Scholar
  46. 46.
    Disney FA, Dillon H, Blumer JL et al (1992) Cephalexin and penicillin in the treatment of group A beta-hemolytic streptococcal throat infections. Am J Dis Child 146:1324–1327PubMedGoogle Scholar
  47. 47.
    Disney F, Hanfling M, Hausinger S (1992) Loracarbef vs. penicillin VK in the treatment of streptococcal pharyngitis in children and adolescents. Pediatr Infect Dis J 11(Suppl):S20–S26PubMedGoogle Scholar
  48. 48.
    Block SL, Hedrick JA, Tyler RD (1992) Comparative study of the effectiveness of cefixime and penicillin V for the treatment of streptococcal pharyngitis in children and adolescents. Pediatr Infect Dis J 11:919–925PubMedCrossRefGoogle Scholar
  49. 49.
    Dajani AS, Kessler SL, Mendelson R et al (1993) Cefpodoxime proxetil vs. penicillin V in pediatric streptococcal pharyngitis/tonsillitis. Pediatr Infect Dis J 12:275–279PubMedGoogle Scholar
  50. 50.
    Gooch WM III, McLinn SE, Aronovitz GH et al (1993) Efficacy of cefuroxime axetil suspension compared with that of penicillin V suspension in children with group A streptococcal pharyngitis. Antimicrob Agents Chemother 37:159–163PubMedGoogle Scholar
  51. 51.
    McCarty JM (1994) Comparative efficacy and safety of cefprozil versus penicillin, cefaclor and erythromycin in the treatment of streptococcal pharyngitis and tonsillitis. Eur J Clin Microbiol Infect Dis 13:846–850PubMedCrossRefGoogle Scholar
  52. 52.
    Pichichero ME, McLinn SE, Gooch WM III et al (1995) Ceftibuten vs. penicillin V in group A beta-hemolytic streptococcal pharyngitis. The Ceftibuten Pharyngitis International Study Group. Pediatr Infect Dis J 14(Suppl 7):S102–S107PubMedGoogle Scholar
  53. 53.
    Nemeth MA, Gooch WM III, Hedrick J et al (1999) Comparison of cefdinir and penicillin for the treatment of pediatric streptococcal pharyngitis. Clin Ther 21:1525–1532PubMedCrossRefGoogle Scholar
  54. 54.
    Gerber MA, Tanz RR, Kabat W et al (1999) Potential mechanisms for failure to eradicate group A streptococci from the pharynx. Pediatrics 104(4 Pt 1):911–917PubMedCrossRefGoogle Scholar
  55. 55.
    Portier H, Chavanet P, Gouyan J et al (1990) Five-day treatment of pharyngotonsillitis with cefpodoxime proxetil. J Antimicrob Chemother 26(Suppl E):79–85PubMedGoogle Scholar
  56. 56.
    Gehanno P, Chiche E (1991) Etraitement des angines a streptocoque beta hemolytique du groupe A par le cefuroxime axetil pendant 4 jours: etude comparative a la penicilline V pendant 10 jours. Med Mal Infect 21:66–70CrossRefGoogle Scholar
  57. 57.
    Milatovic D (1991) Evaluation of cefadroxil, penicillin, and erythromycin in the treatment of streptococcal tonsillopharyngitis. Pediatr Infect Dis J 10:S61–S63PubMedGoogle Scholar
  58. 58.
    Payramond D, Tigaud S, Bemard-Oury C et al (1994) Multicenter comparative trial of cefixime and phenoxymethylpenicillin for group A beta-hemolytic streptococcal tonsillitis. Curr Therapeutic Research 55(A):14–21CrossRefGoogle Scholar
  59. 59.
    Portier H, Chavanet P, Waldner-Combernoux A et al (1994) Five versus ten days treatment of streptococcal pharyngotonsillitis: a randomized controlled trial comparing cefpodoxime proxetil and phenoxymethylpenicillin. Scand J Infect Dis 26:59–66PubMedCrossRefGoogle Scholar
  60. 60.
    Adam D, Group CS, Hostalk U et al (1995) 5-day cefixime therapy for bacterial pharyngitis and/or tonsillitis: comparison with 10-day penicillin V therapy. Infection 23(Suppl 2):S83–S86PubMedCrossRefGoogle Scholar
  61. 61.
    Aujard Y, Boucot I, Brahimi N et al (1995) Comparative efficacy and safety of four-day cefuroxime axetil and ten-day penicillin treatment of group A beta-hemolytic streptococcal pharyngitis in children. Pediatr Infect Dis J 14:295–300PubMedGoogle Scholar
  62. 62.
    Carbon C, Chatelin A, Bingen E et al (1995) A double-blind randomized trial comparing the efficacy and safety of a five-day course of cefotiam hexetil with that of a 10-day course of penicillin V in adult patients with pharyngitis caused by group A β-haemolytic streptococci. J Antimicrob Chemother 35:843–854PubMedCrossRefGoogle Scholar
  63. 63.
    Adam D, Scholz H, Helmerking M (2000) Comparison of short-course (5-day) cefuroxime axetil with a standard 10-day oral penicillin V regimen in the treatment of tonsillopharyngitis. J Antimicrob Chemother 45:23–30PubMedCrossRefGoogle Scholar
  64. 64.
    Pichichero M, Gooch W, Rodriguezm et al (1994) Effective short-course treatment of acute group A β-hemolytic streptococcal tonsillopharyngitis. Arch Pediatr Adolesc Med 148:1053–1060PubMedGoogle Scholar
  65. 65.
    Tack K, Hedrick J, Rothstein E et al (1997) A study of 5-day cefdinir treatment for streptococcal pharyngitis in children. Arch Pediatr Adolesc Med 151:45–49PubMedGoogle Scholar
  66. 66.
    Tack K, Henry D, Gooch W et al (1998) Five-day cefdinir treatment of streptococcal pharyngitis. Antimicrob Agents Chemother 42:1073–1075PubMedGoogle Scholar
  67. 67.
    Lee L, Ayoub E, Pichichero M (2000) Fewer symptoms occur in same-serotype recurrent streptococcal tonsillopharyngitis. Arch Otolarnygol Head Neck Surg 126:1359–1362Google Scholar
  68. 68.
    Stollerman GH (2001) Rheumatic fever in the 21st century. Clin Infect Dis 33:806–814PubMedCrossRefGoogle Scholar
  69. 69.
    Veasy LG, Wiedmeier SE, Orsmond GS et al (1987) Resurgence of acute rheumatic fever in the intermountain area of the United States. N Engl J Med 316:421–427PubMedCrossRefGoogle Scholar
  70. 70.
    Hosier DM, Craenen JM, Teske DW et al (1987) Resurgence of acute rheumatic fever. Am J Dis Child 141:730–733PubMedGoogle Scholar
  71. 71.
    Westlake RM, Graham TP, Edwards KM (1990) An outbreak of acute rheumatic fever in Tennessee. Pediatr Infect Dis J 9:97–100PubMedGoogle Scholar
  72. 72.
    Wald ER, Dashefsky B, Feidt C et al (1987) Acute rheumatic fever in western Pennsylvania and the tristate area. Pediatrics 80:371–374PubMedGoogle Scholar
  73. 73.
    Congeni B, Rizzo C, Congeni J et al (1987) Outbreak of acute rheumatic fever in northeast Ohio. J Pediatr 111:176–179PubMedCrossRefGoogle Scholar
  74. 74.
    Chun LT, Reddy DV, Yamamoto LG (1987) Rheumatic fever in children and adolescents in Hawaii. Pediatrics 79:549–552PubMedGoogle Scholar
  75. 75.
    Bergman A, Werner R (1963) Failure of children to receive penicillin by mouth. N Engl J Med 268:1334–1338PubMedCrossRefGoogle Scholar
  76. 76.
    Green J, Ray S, Charney E (1969) Recurrence rate of streptococcal pharyngitis related to oral penicillin. J Pediatr 75:292–294PubMedCrossRefGoogle Scholar
  77. 77.
    Quinn R (1980) Hemolytic streptococci in Nashville school children. South Med J 73:288–296PubMedGoogle Scholar
  78. 78.
    Critchley I, Blosser-Middleton R, Jones M et al (2002) Phenotypic and genotypic analysis of levofloxacin-resistant clinical isolates of Streptococcus pneumoniae collected in 13 countries during 1999–2000. Int J Antimicrob Agents 20:100–107PubMedCrossRefGoogle Scholar
  79. 79.
    Quinn R, Federspiel C (1973) The occurrence of hemolytic streptococci in school children in Nashville, Tennessee, 1961–1967. Am J Epidemiol 97:22–33PubMedGoogle Scholar
  80. 80.
    James W, Badger G, Dingle J (1960) A study of illnesses in a group of Cleveland families. XIX. The epidemiology of the acquisition of group A streptococci and associated illness. N Engl J Med 262:687–694PubMedCrossRefGoogle Scholar
  81. 81.
    Breese B (1966) The incidence of beta-hemolytic streptococcal illness in a private pediatric practice. Pediatrics 38:277–285PubMedGoogle Scholar
  82. 82.
    Pichichero M, Marsocci S, Murphy M et al (1999) Incidence of streptococcal carriers in private pediatric practice. Arch Pediatr Adolesc Med 153:624–628PubMedGoogle Scholar
  83. 83.
    Brook I (1985) Role of beta-lactamase-producing bacteria in the failure of penicillin to eradicate group A streptococci. Pediatr Infect Dis J 4:491–495Google Scholar
  84. 84.
    Brook I, Gilmore J (1996) Evaluation of bacterial interference and β-lactamase production in management of experimental infection with group A beta-hemolytic streptococci. Antimicrob Agents Chemother 37:1452–1455Google Scholar
  85. 85.
    Brook I (1988) Microbial factors leading to recurrent upper respiratory tract infections. Pediatr Infect Dis J 17:S62–S67CrossRefGoogle Scholar
  86. 86.
    Brook I, Gober A (1999) Interference by aerobic and anaerobic bacteria in children with recurrent group A β-hemolytic streptococcal tonsillitis. Arch Otolaryngol Head Neck Surg 125:552–554PubMedGoogle Scholar
  87. 87.
    Kim K, Kaplan E (1985) Association of penicillin tolerance with failure to eradicate group A streptococci from patients with pharyngitis. J Pediatr 107:681–684PubMedCrossRefGoogle Scholar
  88. 88.
    Pichichero M, Disney F, Talpey W et al (1987) Adverse and beneficial effects of immediate treatment of group A beta-hemolytic streptococcal pharyngitis with penicillin. Pediatr Infect Dis J 6:635–643PubMedCrossRefGoogle Scholar
  89. 89.
    El-Dahar N, Nijazi S, Rawashdeh N et al (1991) Immediate vs. delayed treatment of group A beta-hemolytic streptococcal pharyngitis with penicillin V. Pediatr Infect Dis J 10:126–130CrossRefGoogle Scholar
  90. 90.
    Lafontaine ER, Wall D, Vanlerberg SL et al (2004) Moraxella catarrhalis coaggregates with Streptococcus pyogenes and modulates interactions of S. pyogenes with human epithelial cells. Infect Immun 72:6689–6693PubMedCrossRefGoogle Scholar
  91. 91.
    Poses RM, Cebul RD, Collins M et al (1985) The accuracy of experienced physicians’ probability estimates for patients with sore throats. Implications for decision making. JAMA 254:925–929PubMedCrossRefGoogle Scholar
  92. 92.
    Ebell MH, Smith MA, Barry HC et al (2000) The rational clinical examination. Does this patient have strep throat? JAMA 284:2912–2918PubMedCrossRefGoogle Scholar
  93. 93.
    Dajani A, Taubert K, Ferrieri P et al (1995) Treatment of acute streptococcal pharyngitis and prevention of rheumatic fever: a statement for health professionals. Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, the American Heart Association. Pediatrics 96(4 Pt 1):758–764PubMedGoogle Scholar
  94. 94.
    Committee on Infectious Diseases of the American Academy of Pediatrics (2003) Group A streptococcal infection. In: Pickering LK (ed) Red book. American Academy of Pediatrics, Elkgrove Village, Illinois, pp 573–584Google Scholar
  95. 95.
    American Academy of Pediatrics, American Academy of Family Physicians (2004) Diagnosis and management of acute otitis media: clinical practice guidelines. Pediatrics 113:1451–1466CrossRefGoogle Scholar
  96. 96.
    American Academy of Pediatrics Subcommittee on Management of Sinusitis and Committee on Quality Improvement (2001) Clinical practice guidelines: management of sinusitis. Pediatrics 108:798–808Google Scholar

Copyright information

© Springer-Verlag 2006

Authors and Affiliations

  1. 1.University of Rochester Medical Center, Elmwood Pediatric GroupRochesterUSA

Personalised recommendations